industry leaders, and academicians from around the world to explore groundbreaking innovations in drug research, pharmaceutical sciences, and biotechnology. The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis...
The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...
Funded through NASA’s In Space Production Applications (InSPA) Phase 2 award, the work uses Redwire Corporation’s Pharmaceutical In-space Laboratory (PIL-BOX) technology to crystallize proteins in low Earth orbit — an environment that eliminates...
Ferring Pharmaceuticals announced a new real-world case series demonstrating that re-induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) resulted in complete responses (CR) in approximately 31% (4/13) of patients with high-risk Bacillus...
for executing commercial strategy, accelerating growth initiatives, building strong partnerships with global pharmaceutical companies, and enhancing organizational performance across the business. In her role, McCullough Wood will lead Avid's...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Tranexamic Acid in 0.7% Sodium Chloride Injection in the United States. The product contains the same active ingredient as...
leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). 2nd...
after you start taking JAKAFI or JAKAFI XR and as needed. About Incyte® Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established...
UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage biotechnology company redefining the treatment of autoimmune and...
TIME has named Sprout Pharmaceuticals among just 10 organizations globally shaping the future of health and life sciences. This recognition follows a defining period of momentum for Sprout and its flagship treatment, Addyi. In December 2025, the...
effects. About YARAL Pharma YARAL Pharma Inc. (Parsippany, N.J.) is the U.S. generics subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they’re cared for, YARAL Pharma is...
for ordering from Cardinal and Cencora and for dispensing and overnight delivery from Walmart Specialty Pharmacy. The pharmaceutical component of Lasix ONYU is a novel, high-concentration formulation of the diuretic furosemide, at 30 mg/mL. It...
OrthoTrophix, Inc., a privately held biopharmaceutical company, today announced new clinical data demonstrating a significant association between femoral subchondral bone shape, measured by B-score, and meniscal pathology in patients with knee...
the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access...
dose of glucocorticoid (steroid) medicine. About Neurocrine Biosciences, Inc. Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and...
"We are excited to bring Nintedanib Capsules to market, further strengthening Dexcel's growing portfolio of specialty pharmaceutical products. This approval reflects our commitment to providing high-quality, accessible treatment options for...
them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher...
Burt as Chief Executive Officer. Dr. Burt brings more than 20 years of international leadership experience across the pharmaceutical value chain, including generics, biosimilars, orphan and value-added medicines. He has a strong track record in...
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh...
announced that it has appointed Ron Cohen, M.D., as Chief Executive Officer (CEO). Dr. Cohen is an accomplished biopharmaceutical entrepreneur, CEO, industry leader and advocate, with a 30-year record of value creation through development,...
